Liuxuan Q. Yang

Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Enzyme-responsive targeted nanomedicines: a novel strategy for cancer therapy.

Enzyme-responsive targeted nanomedicines: a novel strategy for cancer therapy.

Journal: Journal of materials chemistry. B

Published: March 09, 2026

Drug-Induced Noninfectious Myocarditis/Pericarditis: A Real-World Pharmacovigilance Study Using the FAERS Database.

Drug-Induced Noninfectious Myocarditis/Pericarditis: A Real-World Pharmacovigilance Study Using the FAERS Database.

Journal: Cardiovascular toxicology

Published: September 30, 2025

ROS-amplifying HKUST-1 nanozyme for enhanced colon cancer therapy.

ROS-amplifying HKUST-1 nanozyme for enhanced colon cancer therapy.

Journal: Biomaterials advances

Published: September 27, 2025

PD-1/PD-L1 inhibitor-induced hyponatremia: a real-world pharmacovigilance analysis using FAERS database.

PD-1/PD-L1 inhibitor-induced hyponatremia: a real-world pharmacovigilance analysis using FAERS database.

Journal: Frontiers in immunology

Published: January 16, 2025

Glucagon-like peptide-1 receptor agonist-induced cholecystitis and cholelithiasis: a real-world pharmacovigilance analysis using the FAERS database.

Glucagon-like peptide-1 receptor agonist-induced cholecystitis and cholelithiasis: a real-world pharmacovigilance analysis using the FAERS database.

Journal: Frontiers in pharmacology

Published: January 09, 2025

Drug-induced Parkinson-like events: a real-world study from 2004 to the first quarter of 2024 based on FAERS.

Drug-induced Parkinson-like events: a real-world study from 2004 to the first quarter of 2024 based on FAERS.

Journal: Frontiers in pharmacology

Published: November 16, 2024

Advances in nano drug delivery systems for enhanced efficacy of emodin in cancer therapy.

Advances in nano drug delivery systems for enhanced efficacy of emodin in cancer therapy.

Journal: International journal of pharmaceutics: X

Published: November 06, 2024

Multifunctional mesoporous polydopamine nanoplatforms for synergistic photothermal-chemotherapy and enhanced immunotherapy in breast cancer treatment.

Multifunctional mesoporous polydopamine nanoplatforms for synergistic photothermal-chemotherapy and enhanced immunotherapy in breast cancer treatment.

Journal: Colloids and surfaces. B, Biointerfaces

Published: October 22, 2024

A Multifunctional MIL-101-NH2(Fe) Nanoplatform for Synergistic Melanoma Therapy.

A Multifunctional MIL-101-NH2(Fe) Nanoplatform for Synergistic Melanoma Therapy.

Journal: International journal of nanomedicine

Published: October 21, 2024

Enhanced anti-tumor efficacy of berberine-loaded mesoporous polydopamine nanoparticles for synergistic chemotherapy and photothermal therapy.

Enhanced anti-tumor efficacy of berberine-loaded mesoporous polydopamine nanoparticles for synergistic chemotherapy and photothermal therapy.

Journal: International journal of pharmaceutics

Published: September 05, 2024

Advancements in Betulinic Acid-Loaded Nanoformulations for Enhanced Anti-Tumor Therapy.

Advancements in Betulinic Acid-Loaded Nanoformulations for Enhanced Anti-Tumor Therapy.

Journal: International journal of nanomedicine

Published: August 28, 2024

Unveiling the potential of HKUST-1: synthesis, activation, advantages and biomedical applications.

Unveiling the potential of HKUST-1: synthesis, activation, advantages and biomedical applications.

Journal: Journal of materials chemistry. B

Published: February 27, 2024

Showing 1-12 of 18

Last Updated: 09/26/2026